Literature DB >> 15730880

Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions.

A Mehta1, L Menalled, M-F Chesselet.   

Abstract

Changes in cellular activity in the subthalamic nucleus are a cardinal feature of Parkinson's disease and occur in rodents after lesions of the nigrostriatal pathway, a model of Parkinson's disease. GABA-ergic neurons from the globus pallidus provide a major input to the subthalamic nucleus. Previous electrophysiological studies revealed temporal changes in the activity of pallidal neurons after nigrostriatal lesions in rats. However, little is known about the impact of these changes on GABAergic transmission in the subthalamic nucleus. We have examined the behavioral responses to a local administration of the GABA A agonist muscimol into the subthalamic nucleus. Muscimol (0.01 and 0.1 microg) induced orofacial dyskinesia in normal rats; this response was blunted 2 weeks but enhanced 2 months after a unilateral lesion of the nigrostriatal pathway. The early decrease in the behavioral response occurred at a time when increased expression of mRNA for glutamic acid decarboxylase, the enzyme of GABA synthesis, and burst firing have been reported in the globus pallidus, suggesting an adaptive post-synaptic response to increased GABAergic transmission in the subthalamic nucleus. In contrast, we now show that glutamic acid decarboxylase mRNA is unchanged in the globus pallidus at the later time point, when electrophysiological changes also subside in this region. The increased behavioral response at this later time point may reflect a decreased activity in GABAergic inputs to the subthalamic nucleus. The results show time-dependent changes in behavioral responses to GABA A receptor stimulation in the subthalamic nucleus which may reflect adaptive changes in postsynaptic inhibitory responses after dopaminergic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730880     DOI: 10.1016/j.neuroscience.2004.11.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.

Authors:  Yann Pelloux; Christelle Baunez
Journal:  Psychopharmacology (Berl)       Date:  2017-04-11       Impact factor: 4.530

2.  Group I mGluRs evoke K-ATP current by intracellular Ca2+ mobilization in rat subthalamus neurons.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Pharmacol Exp Ther       Date:  2013-01-18       Impact factor: 4.030

3.  Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus.

Authors:  Yasin Temel; Laura J Boothman; Arjan Blokland; Peter J Magill; Harry W M Steinbusch; Veerle Visser-Vandewalle; Trevor Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

4.  Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.

Authors:  Artem Minalyan; Lilit Gabrielyan; Claudio Pietra; Yvette Taché; Lixin Wang
Journal:  Front Integr Neurosci       Date:  2019-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.